Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Beasley

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Psychiatry|May 1, 1997
Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophreniaP V Tran, M A Dellva, G D Tollefson, et al.
Journal of Affective Disorders|January 11, 1992
Fluoxetine: no association with suicidality in obsessive-compulsive disorderC M Beasley, J H Potvin, D N Masica, et al.
The Journal of Clinical Psychiatry|July 11, 1992
Lack of association between fluoxetine and suicidality in bulimia nervosaD E Wheadon, A H Rampey, V L Thompson, et al.
The Journal of Clinical Psychiatry|June 1, 1990
The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid populationJ S McCombs, M B Nichol, G L Stimmel, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 22, 1999
Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidolC M Beasley, M A Dellva, R N Tamura, et al.
Journal of Clinical Psychopharmacology|January 5, 2002
Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapyD J Brunswick, J D Amsterdam, J Fawcett, et al.
General Hospital Psychiatry|January 1, 1996
Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney functionN B Levy, M Blumenfield, C M Beasley, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|December 1, 1993
Evaluation of suicidality during pharmacologic treatment of mood and nonmood disordersG D Tollefson, J Fawcett, G Winokur, et al.
The American Journal of Psychiatry|July 1, 1997
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter studyJ D Amsterdam, J Fawcett, F M Quitkin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 1, 1997
Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trialC M Beasley, S H Hamilton, A M Crawford, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Psychiatry|May 1, 1997
Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophreniaP V Tran, M A Dellva, G D Tollefson, et al.
Journal of Affective Disorders|January 11, 1992
Fluoxetine: no association with suicidality in obsessive-compulsive disorderC M Beasley, J H Potvin, D N Masica, et al.
The Journal of Clinical Psychiatry|July 11, 1992
Lack of association between fluoxetine and suicidality in bulimia nervosaD E Wheadon, A H Rampey, V L Thompson, et al.
The Journal of Clinical Psychiatry|June 1, 1990
The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid populationJ S McCombs, M B Nichol, G L Stimmel, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 22, 1999
Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidolC M Beasley, M A Dellva, R N Tamura, et al.
Journal of Clinical Psychopharmacology|January 5, 2002
Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapyD J Brunswick, J D Amsterdam, J Fawcett, et al.
General Hospital Psychiatry|January 1, 1996
Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney functionN B Levy, M Blumenfield, C M Beasley, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|December 1, 1993
Evaluation of suicidality during pharmacologic treatment of mood and nonmood disordersG D Tollefson, J Fawcett, G Winokur, et al.
The American Journal of Psychiatry|July 1, 1997
Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter studyJ D Amsterdam, J Fawcett, F M Quitkin, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 1, 1997
Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trialC M Beasley, S H Hamilton, A M Crawford, et al.
Pageof 6